1 Introduction Management of moderately to severely active ulcerative colitis (UC) involves a range of therapeutic options, targeting different sites in its inflammatory pathway. Advanced therapies, including biologic therapies and small molecules, have significantly changed the therapeutic paradigm for UC over the past two decades.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Tamar
Contact Tamar, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack